Related Experiment Video

Updated: Aug 8, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

990

The Cardiovascular Manifestations of COVID-19

David W Louis1, Marwan Saad1, Shilpa Vijayakumar1

  • 1Lifespan Cardiovascular Institute, 593 Eddy Street, RIH APC 730, Providence, RI 02903, USA; Department of Medicine, Division of Cardiology, Alpert Medical School of Brown University, 222 Richmond Street, Providence, RI 02903, USA.

Heart Failure Clinics
|March 2, 2023
PubMed

Insights

The COVID-19 pandemic, caused by SARS-CoV-2, significantly impacts cardiovascular health, leading to serious complications like heart failure and thrombosis. Understanding these cardiovascular risks is crucial for managing patient outcomes during the pandemic and beyond.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • The Coronavirus 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) virus, has led to widespread illness and death globally.
  • While primarily a respiratory illness, COVID-19 frequently presents with significant cardiovascular manifestations.

Purpose of the Study:

  • To review the intricate relationship between cardiovascular risk factors and patient outcomes in the context of COVID-19.
  • To elucidate the diverse cardiovascular manifestations observed in patients with COVID-19.
  • To examine the cardiovascular complications potentially associated with COVID-19 vaccination.

Main Methods:

  • This review synthesizes existing literature on COVID-19 and cardiovascular health.
  • Data from clinical studies and epidemiological reports were analyzed.
  • Focus was placed on identifying patterns in cardiovascular complications and outcomes.

Main Results:

  • COVID-19 is associated with a higher incidence of cardiovascular complications, including acute coronary syndromes, thrombosis, heart failure, and arrhythmias.
  • These cardiovascular manifestations are linked to increased morbidity and mortality rates in COVID-19 patients.
  • Emerging data also suggests potential cardiovascular implications of COVID-19 vaccination.

Conclusions:

  • Cardiovascular health is a critical determinant of outcomes for patients with COVID-19.
  • Recognizing and managing COVID-19-related cardiovascular complications is essential for improving patient survival.
  • Further research is warranted to fully understand the long-term cardiovascular effects of SARS-CoV-2 infection and vaccination.

Keywords:
Acute coronary syndromeCOVID-19Heart failureThrombosis

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.3K
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients03:47

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients

Published on: July 12, 2024

849

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
20
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
31
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
21
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
15
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
17